Assessing the exposome to elucidate key exposures and causal biomarkers to improve chronic disease risk determination, prevention, and diagnosis in the Prospective Urban and Rural Epidemiology (PURE) study cohort.

评估暴露组以阐明关键暴露和因果生物标志物，以改善前瞻性城乡流行病学 (PURE) 研究队列中慢性病风险的确定、预防和诊断。

• 批准号: 454922
• 负责人: Gill Bibanjeet
• 金额: $ 6.56万
• 依托单位: McMaster University
• 依托单位国家: 加拿大
• 项目类别: Fellowship Programs
• 财政年份: 2021
• 资助国家: 加拿大
• 起止时间: 2021-10-01 至 2023-10-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=454922&lang=en
• 关键词: Bioinformatics; Biomarkers For Disease; Environmental Exposure Assessment; Epidemiology; Metabolite Analysis; Population Health; Proteomics; Statistical Genetics

An individual's exposome encompasses a collection of human environmental exposures from conception onwards, complementing the genome to better understand disease risk. Given the variability and unique nature of an individual's exposome, it offers a promis

个人的暴露组包括从受孕开始的人类环境暴露的集合，补充基因组以更好地了解疾病风险。考虑到个体麻烦的可变性和独特性，它提供了一个承诺，